Associations between central obestiy and indexes of hemostatic, carbohydrate and lipid metabolism. Results of a 1‐year intervention from the Oslo Diet and Exercise Study
暂无分享,去创建一个
[1] [Optimum physical working capacity, its measurement and change as a result of the working fatigue]. , 1954, Arbeitsphysiologie; internationale Zeitschrift fur angewandte Physiologie.
[2] H. Arnesen,et al. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis. , 2009, Scandinavian journal of haematology.
[3] K. Pennert,et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.
[4] P. Björntorp,et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.
[5] M. Alessi,et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. , 1986, Metabolism: clinical and experimental.
[6] T. Kooistra,et al. Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2 , 1988, Thrombosis and Haemostasis.
[7] P. Björntorp. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. , 1988, Diabetes/metabolism reviews.
[8] B. Larsson. Fat distribution and risk for death, myocardial infarction and stroke , 1988 .
[9] J. Verheijen,et al. Daytime Fluctuations in Blood of Tissue-Type Plasminogen Activator (t-PA) and Its Fast-Acting Inhibitor (PAI-1) , 1988, Thrombosis and Haemostasis.
[10] G. Hallmans,et al. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. , 1989, Atherosclerosis.
[11] E. Bleecker,et al. Effects of body composition and exercise capacity on glucose tolerance, insulin, and lipoprotein lipids in healthy older men: a cross-sectional and longitudinal intervention study. , 1989, Metabolism: clinical and experimental.
[12] L. Sjöström,et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. , 1990, Metabolism: clinical and experimental.
[13] U. Smith,et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. , 1990, Metabolism: clinical and experimental.
[14] P. Björntorp. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. , 1990, Arteriosclerosis.
[15] A. Folsom,et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.
[16] Skinfold and body circumferences as measures of body fat patterning in a French female active population: relationships with the metabolic risk profile. , 1991, Journal of clinical epidemiology.
[17] A. Folsom,et al. Anthropometric predictors of coronary heart disease and total mortality: findings from the US Railroad Study. , 1991, American journal of epidemiology.
[18] D. Holbert,et al. Effects of fitness level and the regional distribution of fat on carbohydrate metabolism and plasma lipids in middle- to older-aged men. , 1991, Metabolism: clinical and experimental.
[19] A. Folsom,et al. Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. , 1991, Journal of clinical epidemiology.
[20] A Tremblay,et al. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. , 1991, The American journal of clinical nutrition.
[21] J. Skinner,et al. Validity of Futrex-5000 for body composition determination. , 1992, Medicine and science in sports and exercise.
[22] Strenuous exercise, plasma fibrinogen, and factor VII activity , 1992 .
[23] L. Sjöström,et al. The morphology and metabolism of intraabdominal adipose tissue in men. , 1992, Metabolism: clinical and experimental.
[24] A. Folsom,et al. Change in waist-hip ratio with weight loss and its association with change in cardiovascular risk factors. , 1992, The American journal of clinical nutrition.
[25] J. Cooper,et al. Strenuous exercise, plasma fibrinogen, and factor VII activity. , 1992, British heart journal.
[26] Theodesinvestigators. The Oslo Diet and Exercise Study (ODES): design and objectives. , 1993, Controlled clinical trials.
[27] R R Wing,et al. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[28] Relationships of lipid and glucose metabolism with waist-hip ratio and physical fitness in obese men. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[29] J. Seidell,et al. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. , 1994, Atherosclerosis.
[30] S. Corrao,et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. , 1994, American journal of hypertension.
[31] B. Balke. Optimale körperliche Leistungsfähigkeit, ihre Messung und Veränderung infolge Arbeitsermüdung , 1954, Arbeitsphysiologie.